221905-35-7

Rp-8-CPT-cAMP is a structural combination of the lipophilic and non-hydrolyzable cAMP analogs, 8-CPT-cyclic AMP and Rp-cyclic AMPS . It functions as a site-selective inhibitor of protein kinase A (PKA) type I and II, with preference towards site A of type I and site B of type II. By occupying cAMP binding sites at the regulatory subunit of PKA, Rp-8-CPT-cAMP prevents the kinase holoenzyme from dissociative activation.

Rp-8-CPT-cAMP is a structural combination of the lipophilic and non-hydrolyzable cAMP analogs, 8-CPT-cyclic AMP and Rp-cyclic AMPS . It functions as a site-selective inhibitor of protein kinase A (PKA) type I and II, with preference towards site A of type I and site B of type II. By occupying cAMP binding sites at the regulatory subunit of PKA, Rp-8-CPT-cAMP prevents the kinase holoenzyme from dissociative activation.[Cayman Chemical]

Store at -20°C

[1] FRANK SCHWEDE . Cyclic nucleotide analogs as biochemical tools and prospective drugs[J]. Pharmacology & Therapeutics, 2000, 87 2: Pages 199-226. DOI: 10.1016/s0163-7258(00)00051-6
[2] W R DOSTMANN. Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3’,5’-cyclic phosphorothioates.[J]. The Journal of Biological Chemistry, 1990, 265 18: 10484-10491.
[3] B T GJERTSEN. Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. Basal cAMP-kinase activity modulates interleukin-1 beta action.[J]. The Journal of Biological Chemistry, 1995, 270 35: 20599-20607. DOI: 10.1074/jbc.270.35.20599